A meta-analysis of 140 studies by investigators from the Cochrane Collaboration shows that oxytocin may not be the best choice for prevention of postpartum hemorrhage, despite the current recommendation from the World Health Organization (WHO). PLUS: Commentary on the findings from our Maternal Mortality Series Editor, Carolyn Zelop, MD.
Maternal Mortality Hemorrhage
Ob/gyns must be ready to move quickly when a patient exhibits the sudden and unexpected signs of anaphylactoid syndrome (ASP).
Two Contemporary OB/GYN readers share their experiences with losing a patient.
Allegations in this case include extended use of oxytocin and allowing labor to continue too long.
The aim of this paper is not to outline a specific medical-surgical algorithm for managing PPH, but rather to give an overview for system-wide preparedness that should be considered in planning to mitigate this frequent, potentially life-threatening, obstetrical emergency.
A collection of standards, guidelines, tools and articles for the OB managing postpartum hemorrhage.
A drug that is low cost and easy to administer may help prevent maternal deaths, according to results of a randomized clinical trial. Plus: Does air pollution affect menstrual regularity? Also: According to a statement published by the American Heart Association (AHA), breast cancer patients may be at increased risk of cardiovascular disease (CVD).